Filtering by:
Kidney CancerStudy: Getting Enough Exercise Lowers Risk of 7 Cancers
Getting recommended amounts of physical activity is linked to a lower risk for 7 cancer types, according to a study from the American Cancer Society, the National Cancer Institute, and the Harvard T.H. Chan School of Public Health.
Study: Millennials’ Increased Risk for Some Obesity-Linked Cancers — 5 Takeaways
Researchers at the American Cancer Society found that 6 cancers proven to be related to obesity are increasing more rapidly in people younger than 50 than those older than 50. To understand what this study means to you and your loved ones, read these 5 key takeaway messages.
FDA Expands Approval for Sutent (Sunitinib) After Kidney Cancer Surgery
The US Food and Drug Administration (FDA) has approved Sutent (sunitinib) to treat adults who are at high risk of kidney cancer returning after they’ve had a nephrectomy, surgical removal of a kidney.
FDA Approves a Biosimilar to Avastin for Cancer Treatment
The US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab-awwb) as the first biosimilar drug for treating cancer. It works the same way as Avastin (bevacizumab).
Survivor: ‘I wasn’t supposed to have kidney cancer. But I did!’
Jamie Swift is not your typical kidney cancer survivor. The average age at diagnosis is 64. It’s also more common in men than women. Risk factors include smoking, obesity, exposure to cancer-causing substances in the workplace, and certain inherited conditions. Swift had none of these risk factors.